Graph Therapeutics
@graphtx.bsky.social
71 followers 550 following 31 posts
Improving the lives of patients with immune-mediated diseases. We combine complex primary disease models with advanced ML to bridge the gap between pre-clinical models & clinical applications. 🌐 graphtx.com ✏️ graphtx.substack.com
Posts Media Videos Starter Packs
graphtx.bsky.social
By laying the groundwork with this collaboration, we’ll be able to continue to drive techbio innovation and create new opportunities that can transform how therapies are developed for patients with immune-mediated diseases worldwide. 🚀🌟
graphtx.bsky.social
This partnership combines our AI-driven lab-in-the-loop approach with BIIE’s immune engineering expertise. By sharing resources, data, & insights, the goal is to jointly bridge the gap between lab discoveries & clinical impact, addressing critical unmet needs in the inflammation & immunology space.
graphtx.bsky.social
✨ Some exciting news: We’re announcing a strategic partnership with the Botnar Institute of Immune Engineering (BIIE) to accelerate the development of precision medicines for immune-mediated diseases!
graphtx.bsky.social
To learn more, reach out for a meeting or drop by our presentation:

📅 When: 5 November, 10:40
🎤 Speaker: Gregory Vladimer
📍 Where: Presenting Company Theater 1
graphtx.bsky.social
Meet the Graph team at #BIOEurope in Vienna from 3 - 5 November! We’ll be sharing how Graph is leading the way towards precision immunology drug discovery and development through capturing, mapping, and predicting patient immune dysfunction at scale.
graphtx.bsky.social
Meet the team behind Graph and say hello to Desy Vallorani, Research Associate! 🚢🔬

With Desy’s help, we’re generating high-quality and contextually rich datasets for complex immune diseases. ➕✖️
graphtx.bsky.social
Salut Lausanne 🇨🇭, Graph’s Senior Research Scientist Rin Okumura will be at the 2nd Symposium on the Immunobiology of Pattern Recognition Receptors hosted by @unil.bsky.social from 1 - 2 October! We’re excited to explore and discuss the latest discoveries in innate immune research. 💪 🧬
graphtx.bsky.social
👏A big thank you to the AITHYRA symposium organizers for a fantastic 3-days of scientific conversation and connection!
graphtx.bsky.social
@gregvladimer.bsky.social, Aishwarya Parthasarathy, Nathan Benaich, and @georgwinter.bsky.social wrapped up the final session of the @aithyra.bsky.social symposium with a panel discussion about building AI-first spinouts and ventures, and how to improve science & tech collaborations. 🚀✨
graphtx.bsky.social
How can we best drive ideation, funding, and operation of academic-spin outs and academically linked ventures that span interdisciplinary fields, while keeping the end goal of patient success in mind? 💡⚙️
graphtx.bsky.social
From our team, @gregvladimer.bsky.social, @rogepese.bsky.social, Bojan Vilagos, and @izepb.bsky.social will be attending the symposium. Come by and say hi! 👋
graphtx.bsky.social
On 10 September, @gregvladimer.bsky.social will be chairing the final session of the symposium, and will participate as part of a round table on techbio spin outs, fundraising and commercialization. 💡
graphtx.bsky.social
Hey Vienna 🇦🇹, Graph will be at the @aithyra.bsky.social Symposium “AI for Life Science” from 8 - 10 September! We’re looking forward to attending many of the talks by an outstanding line up of speakers. Let us know if you’re around and let’s talk! 💬 ☕
graphtx.bsky.social
Meet the team behind Graph and say hello to Christophe Boudesco, VP Immunology! 👋 🥼

Better algorithms and better biological validations go hand in hand. The expertise that Christophe brings will help the team at Graph reduce biological uncertainty early and systematically. ➕✖️
graphtx.bsky.social
Servus Vienna! 🇦🇹 Christophe Boudesco, Graph’s VP Immunology, will be at the 19th International Congress of Immunology (IUIS 2025) in Vienna from 17 - 22 August. Let us know if you’ll be around and let’s talk translational immunology! 🔬🧬
graphtx.bsky.social
With its strong academic network & public-private partnerships, Vienna takes a leading role in shaping the bio x AI ecosystem. We're excited to be a part of this and to help it grow! 🌿

Great read about the history & scope of biotech in the 🇦🇹 capital. Check it out! ➡️ www.labiotech.eu/in-depth/vie...
graphtx.bsky.social
Meet the team behind Graph and say hello to @kdris.bsky.social, Head of AI! 👋 🦜

Target discovery in immunology is a complex process. Bringing together individuals who have deep knowledge in adjacent domains helps us approach the challenges from multiple angles. ➕✖️
graphtx.bsky.social
Happy 1st bday, Graph! 🎈 We've gone from an idea to a team of 11 (recruiting #12!), building lab-in-the-loop infrastructure, fueled by $5M in funding & academic collabs. We had a great time celebrating our journey with the team & reflecting on our mission to rebalance dysregulated immune systems! ➕✖️
graphtx.bsky.social
Meet the team behind Graph and say hello to Daniel Thomas, MLOps & data engineer! 👋 💬

We’re excited to have you along for the journey! Here’s to discovering better therapeutics for immune-mediated diseases by bridging the gap between biology and machine learning. ➕✖️
Poster with a portrait photo of Daniel Thomas, MLOps & data engineer for Graph Therapeutics.
graphtx.bsky.social
💡How are we using disease perturbational modeling & AI to transform the treatment of immunological diseases? In the AWS Health podcast, Graph's co-founder & CEO @gregvladimer.bsky.social talks science, tech, & where the future is headed in target discovery.

🎧 Check out the podcast! ➡️ bit.ly/43b5LAw
#123, Decoding Immune Cell Behavior to Transform Treatment Discovery with Gregory Vladimer from Graph Therapeutics
Graph Therapeutics combines AI-driven perturbation modeling with multi-omics data to develop targeted therapies for patients with complex immune-mediated diseases who currently lack effective treatmen...
bit.ly
Reposted by Graph Therapeutics
kdris.bsky.social
Excited to be joining the panel discussion later today! ✨

Mark your calendars! 📅 The @WiMLWorkshop Social returns to @iclrconf!

🗓️ Friday, April 25th, 2025
⏰ 12:30 PM - 2:00 PM
📍 Hall 1 Apex, Singapore Expo
iclr.cc/virtual/2025...

lu.ma/ftdnjnf9

#ICLR2025
graphtx.bsky.social
Graph receives the Deep Tech Life Science Seed Financing grant from the Austria Wirthschafts Service (AWS) worth EUR 1.1M! This accelerates our AI-driven platform technology and lab-in-the-loop approach to discover better data, targets, validation & biomarkers for immune & inflammatory diseases. 🎯🧬
Poster of news from Graph Therapeutics, the Graph Therapeutics logo in the top right corner, with the headline in the center that reads: Graph Therapeutics awarded EUR 1.1M Deep Tech Seed Financing from the Austria Wirtschafts Service (AWS). A logo of the AWS in on the bottom left hand corner. A poster of a new story from Graph Therapeutics, with the Graph Therapeutics logo in the top right corner. The body text reads: "Graph has been awarded the Deep Tech Life Science Seed Financing grant from the AWS, an Austrian government program that supports techbio projects based on applied research and development. This program helps advance Graph’s clinically realistic precision immunology platform." The AWS logo is in the bottom right hand corner.
graphtx.bsky.social
Hey Singapore, @kdris.bsky.social will be at ICLR 2025 from 24 - 28 April! We’re looking forward to hearing about the latest discoveries in biology, AI, and deep learning. Let us know if you’ll be around! 🇸🇬
Graph at ICLR 2025 in Singapore from 24 - 28 April. Meet us there! A portrait of Katherine Driscoll, Head of AI at Graph, standing in front of a blackboard with mathematical formulas.